EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma

Zhuang Fan, Qing Pei, Haojie Sun, Haiyan Zhang, Zhigang Xie, Tao Zhang, Chong Ma iD

Advanced Science · 2025

DOI: 10.1002/advs.202414592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhuang Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, Jilin, 130033, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Porphyrins, Phototherapy, Melanoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Health Research Talent Special Project, Science and Technology Research Project of the Education Department of Jilin Province, Jilin University Bethune Medical Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of melanoma, the third most common skin cancer, has been on the rise in recent years. In addition, it has a high mortality rate due to its high aggressiveness. Phototherapy, as a promising treatment method, can effectively kill tumor cells, but it is incapable of the treatment of tumor metastasis. Herein, a nanomaterial (TPC@OVA NPs) is developed for phototherapy in conjunction with immunotherapy against melanoma. TPC, as a derivative of porphyrin, is used as a photosensitizer with excellent biosafety and photostability. After assembly with ovalbumin (OVA), TPC@OVA NPs with vaccine properties is formed, which can not only ablate the primary tumor but also induce immunogenic cell death (ICD). In addition, DC cells can be stimulated to mature by exogenous OVA, enhancing the immune response against tumors by further activating T lymphocytes. Combined with immune checkpoint inhibitor aPD‐1, the immune microenvironment is reshaped, and the increased activity of immunotherapy are validated. This work highlights the potential of combining phototherapy and immunotherapy against metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyPorphyrinsPhototherapyMelanomaNanostructuresSkin NeoplasmsAnimalsMiceHumansPhotosensitizing AgentsCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

combination therapyimmunogenic cell deathmelanomaphototherapytumor vaccine

Substanzen

PorphyrinsPhotosensitizing Agents

Autor:innen und Institutionen

  • China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, Jilin, 130033, P. R. China.
  • State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.

ORCID-Profile: Chong Ma

Förderung

  • Jilin Province Health Research Talent Special Project
  • Science and Technology Research Project of the Education Department of Jilin Province
  • Jilin University Bethune Medical Department

Zitieren

APA

Fan, Z., Pei, Q., Sun, H., Zhang, H., Xie, Z., Zhang, T., & Ma, C. (2025). A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma. Advanced Science. https://doi.org/10.1002/advs.202414592

Vancouver

Fan Z, Pei Q, Sun H, Zhang H, Xie Z, Zhang T, et al. A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma. Advanced Science. 2025. doi:10.1002/advs.202414592

BibTeX
@article{Fan2025,
  author = {Fan, Zhuang and Pei, Qing and Sun, Haojie and Zhang, Haiyan and Xie, Zhigang and Zhang, Tao and Ma, Chong},
  title = {A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202414592}
}
Kostenlos starten →